Ionis Pharmaceuticals Inc’s filing revealed that its EVP, Chief Human Resources Ofc Devers Shannon L. unloaded Company’s shares for reported $3.76 million on Jan 07 ’26. In the deal valued at $85.08 per share,44,199 shares were sold. As a result of this transaction, Devers Shannon L. now holds 17,494 shares worth roughly $1.4 million.
Then, Devers Shannon L. bought 9,390 shares, generating $795,117 in total proceeds.
Before that, Swayze Eric sold 23,463 shares. Ionis Pharmaceuticals Inc shares valued at $1,856,325 were divested by the EVP Research at a price of $79.12 per share. As a result of the transaction, Swayze Eric now holds 30,453 shares, worth roughly $2.45 million.
JP Morgan upgraded its Ionis Pharmaceuticals Inc [IONS] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Goldman’s analysts, who increased its forecast for the stock in late September from “a Sell” to “a Neutral”. BMO Capital Markets also remained covering IONS and has increased its forecast on September 03, 2025 with a “an Outperform” recommendation from previously “Market perform” rating. Morgan Stanley revised its rating on July 31, 2025. It rated IONS as “an Overweight” which previously was an “an Equal-weight”.
Price Performance Review of IONS
On Monday, Ionis Pharmaceuticals Inc [NASDAQ:IONS] saw its stock fall -1.52% to $80.3. Over the last five days, the stock has gained 0.79%. Ionis Pharmaceuticals Inc shares have risen nearly 129.63% since the year began. Nevertheless, the stocks have risen 1.50% over the past one year.
How much short interest is there in Ionis Pharmaceuticals Inc?
A steep rise in short interest was recorded in Ionis Pharmaceuticals Inc stocks on 2025-12-15, growing by 1.86 million shares to a total of 16.09 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 14.22 million shares. There was a rise of 11.58%, which implies that there is a positive sentiment for the stock.
